Arthritis & Rheumatism

Rheumatoid arthritis: Biologics in second-line therapy show benefit

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined 9 biotechnologically produced drugs for the treatment of adults with rheumatoid arthritis in whom prior pharmacological treatment had failed. ...

Diseases, Conditions, Syndromes

New technologies improving the odds for osteoporosis patients

The older we get, the greater our risk of developing osteoporosis becomes. The fragile bone disease affects about 9 million Americans, and experts from the National Osteoporosis Foundation predict that it will be responsible ...

Arthritis & Rheumatism

Prolactin reduces arthritis inflammation

Inflammatory joint diseases such as rheumatoid arthritis are the result of cartilage damage and loss. Chondrocytes are the only cells that are found in cartilage and their death is linked to decreased cartilage health.

Arthritis & Rheumatism

Statin therapy may reduce risk of osteoarthritis

(Medical Xpress)—Regular use of cholesterol-lowering medicines calledstatins may reduce a person's chances of developing the degenerative joint disease osteoarthritis, UK scientists have found.

Arthritis & Rheumatism

Can stem cells help those with arthritis?

Stems cells taken from just a few grams of body fat are a promising weapon against the crippling effects of osteoarthritis.

Arthritis & Rheumatism

Ultrasound model IDs residual joint inflammation in RA

(HealthDay)—A model including ultrasound (US) assessment of the wrist, metacarpophalangeal (MCP), ankle, and metatarsophalangeal (MTP) joints is highly sensitive for detecting B-mode and Doppler joint inflammation in patients ...

page 4 from 7